Clinical and molecular characterisation of metastatic papillary thyroid cancer according to radioiodine therapy outcomes.
Joana Simões-PereiraAna SaramagoRicardo RodriguesMarta PojoCarolina PiresMariana HortaDolores López-PresaMiguel RitoRafael CabreraTeresa C FerreiraValeriano LeiteBranca Maria CavacoPublished in: Endocrine (2023)
Early identification of molecular markers in primary tumours may help to predict RAI therapy avidity, the response of metastatic lesions and to select the patients that may benefit the most from other systemic therapies.
Keyphrases
- papillary thyroid
- lymph node metastasis
- squamous cell carcinoma
- end stage renal disease
- small cell lung cancer
- newly diagnosed
- ejection fraction
- chronic kidney disease
- peritoneal dialysis
- prognostic factors
- type diabetes
- single molecule
- patient reported outcomes
- mesenchymal stem cells
- adipose tissue
- insulin resistance